Health
Research team identifies potential drug to treat SARS-CoV-2 – Medical Xpress
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by…
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).
The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition.
The team’s leaders are College of Science professor Wenshe Ray Liu, professor and…
-
Noosa News19 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General18 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General20 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News21 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate